Intrexon | XON - Przychody Ze Sprzedaży





Obroty Zmiana Data
Agenus USD 33.7M 500K 2026-03
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 10.1B 1.48B 2026-06
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Incyte USD 1.67B 400M 2026-06
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
MacroGenics USD 20.8M 20.43M 2026-03
MannKind USD 109.37M 19.17M 2026-06
Merck USD 16.6B 310M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Veracyte USD 150.32M 11.25M 2026-06
Xencor USD 51.22M 46.71M 2026-06